Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 15/20 | 0.77 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.64 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.63 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.63 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL7477183 | 0.94 | CHRM1 (0.68) | CHRM1 | |
| SCHEMBL7462827 | 0.91 | CHRM1 (0.78) | CHRM1CHRM4CHRM2CHRM5CHRM3 | |
| SCHEMBL6913185 | 0.87 | CHRM1 (1.00) | CHRM1CHRM4CHRM2CHRM5CHRM3 | |
| Oxalic Acid SCHEMBL7464573 | 0.85 | CHRM1 (0.69) | CHRM1CHRM4 | |
| SCHEMBL7469869 | 0.81 | CHRM1 (0.72) | CHRM1CHRM4CHRM2CHRM5CHRM3 | |
| SCHEMBL27456329 | 0.81 | CHRM1 (0.71) | CHRM1CHRM4CHRM2CHRM5CHRM3 | |
| Oxalic Acid SCHEMBL7609648 | 0.81 | CHRM1 (0.86) | CHRM1CHRM4CHRM2CHRM5CHRM3 | |
| Pyridine SCHEMBL27455798 | 0.80 | CHRM1 (0.84) | CHRM1CHRM4CHRM2CHRM5CHRM3 | |
| SCHEMBL6907655 | 0.80 | CHRM1 (0.82) | CHRM1CHRM4 | |
| Hydrochloric Acid SCHEMBL7900811 | 0.80 | CHRM4 (0.97) | CHRM1CHRM4CHRM2CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0734259-B1 | Use of piperidine compounds in the treatment of schizophrenia | NOVO NORDISK AS (DK) | 2002-06-12 | — | — | EP | claimed |
| EP-0687265-B1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK AS (DK) | 2002-01-23 | — | — | EP | claimed |
| US-5773452-A | ALZHEIMER'S DISEASE; COGNITION ACTIVATORS | NOVO NORDISK ALS (DK) | 1998-06-30 | — | — | US | claimed |
| CN-1133008-A | Antipsychotic method | NOVO NORDISK AS (DK) | 1996-10-09 | — | — | CN | claimed |
| US-5545638-A | USING A 3-(TETRAHYDROPYRID-3-YL-) SUBSTITUTED (OXA- OR THIA-)DIAZOLE COMPOUND | NOVO NORDISK A/S (DK) | 1996-08-13 | — | — | US | claimed |
| EP-0687265-B1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK AS (DK) | 2002-01-23 | — | — | EP | disclosed |
| EP-0709094-B1 | Tetrahydropyridine oxadiazole or thiadiazole compound for treating anxiety | LILLY CO ELI (US) | 2000-04-05 | — | — | EP | disclosed |
| US-5708014-A | SUBSTITUTED TETRAHYDROPYRIDINYL-1,2,5-OXADIAZOLES OR THIADIAZOLES | ELI LILLY AND COMPANY (US) | 1998-01-13 | — | — | US | disclosed |
| EP-0709094-A2 | Method for treating anxiety using a tetrahydropyridine oxadiazole or thiadiazole compound | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |